financetom
Business
financetom
/
Business
/
AtlasClear Closes Additional $2 Million in Financing, Names Sandip Patel as CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AtlasClear Closes Additional $2 Million in Financing, Names Sandip Patel as CFO
Sep 24, 2025 6:42 AM

09:01 AM EDT, 09/24/2025 (MT Newswires) -- AtlasClear ( ATCH ) said Wednesday that it has raised additional $2 million in funding, completing a previously announced $5 million in total financing.

The company said board member Sandip Patel invested $1 million in promissory notes and will join the company as chief financial officer.

Sixth Borough Capital invested an additional $450,000 in the notes, bringing its total investment to $950,000, the company said.

Shares of AtlasClear ( ATCH ) were up more than 14% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's Germany Plant Halts Production After Suspected Arson Attack
Tesla's Germany Plant Halts Production After Suspected Arson Attack
Mar 5, 2024
08:37 AM EST, 03/05/2024 (MT Newswires) -- Tesla (TSLA) on Tuesday has halted production in its gigafactory in Germany, which was left without power after a suspected arson attack on a nearby electricity pylon, several media outlets reported. A blaze in the power grid supplying the Tesla plant was extinguished by the fire brigade and did not spread to the...
Dyne Therapeutics's Q4 Net Loss Widens; Shares Down Pre-Bell
Dyne Therapeutics's Q4 Net Loss Widens; Shares Down Pre-Bell
Mar 5, 2024
08:34 AM EST, 03/05/2024 (MT Newswires) -- Dyne Therapeutics ( DYN ) reported a Q4 net loss of $1.09 per diluted share, wider than its loss of $0.74 a year earlier. Analysts polled by Capital IQ expected a loss of $0.93 per share. The company reported no Q4 revenue, matching analyst expectations. The biopharmaceutical company reported it had $123.1 million...
Patrick Industries Insider Sold Shares Worth $806,805, According to a Recent SEC Filing
Patrick Industries Insider Sold Shares Worth $806,805, According to a Recent SEC Filing
Mar 5, 2024
08:35 AM EST, 03/05/2024 (MT Newswires) -- John A Forbes, Director, on March 01, 2024, sold 6,793 shares in Patrick Industries ( PATK ) for $806,805. Following the Form 4 filing with the SEC, Forbes has control over a total of 34,682 shares of the company, with 34,682 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/76605/000007660524000090/xslF345X03/wk-form4_1709605019.xml Price: 121.19, Change: +0.28, Percent Change:...
FSD Pharma Presents
FSD Pharma Presents "Positive" Phase 1 Lucid-21-302 Results at ACTRIMS Forum
Mar 5, 2024
08:35 AM EST, 03/05/2024 (MT Newswires) -- FSD Pharma Inc. ( HUGE ) on Tuesday announced its participation in Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum held during Feb. 29 - Mar 2, in West Palm Beach, Florida. ACTRIMS, founded in 1995, is comprised exclusively of Multiple Sclerosis (MS) researchers, clinicians and key stakeholders. FSD...
Copyright 2023-2026 - www.financetom.com All Rights Reserved